NICE Seeking Greater Access to Trial Data for Drug Appraisals

Drug Industry Daily
A A
The UK’s cost-effectiveness agency plans to seek access to clinical trial data from European regulators if drug companies fail to supply relevant information, according to an updated process guide for developing technology appraisal recommendations.

To View This Article:

Login

Subscribe To Drug Industry Daily